RSS   Newsletter   Contact   Advertise with us
Post Online Media

Enanta Pharmaceuticals appoints new board member

Enanta PharmaceuticalsEnanta Pharmaceuticals, a biotechnology company, announced the appointment of Lesley Russell to its board of directors.

Dr. Russell will also serve as a member of Enanta’s audit committee and its nominating and corporate governance committee, effective as of January 1, 2017.

Dr. Russell has over two decades of clinical, regulatory and drug development expertise.

Dr. Russell currently serves as Chief Medical Officer at Innocoll Holdings.

She held executive management positions at TetraLogic Pharmaceuticals, where she held the role of Chief Operating Officer from 2013 through 2016, and at Teva Pharmaceuticals, where she was Senior Vice president and Global Head of Research and Development from 2011-2012.

At Teva, Dr. Russell led a team of over 1,500 and was responsible for all aspects of global drug development. She spent over 10 years at Cephalon where she held positions of increasing responsibility from 2000 -2011, most recently serving as Executive Vice President and Chief Medical Officer.

Dr. Russell currently serves on the Boards of Directors of AMAG Pharmaceuticals, Endocyte Pharmaceuticals and Melmark.

Dr. Russell received a MB.Ch.B. degree from the University of Edinburgh, Scotland, Faculty of Medicine. She is a member of the Royal College of Physicians, UK, and is registered with the General Medical Council, UK.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy